Buchumschlag

Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors

Gespeichert in:

Bibliographische Detailangaben
Datum:	2014
Hauptverfasser:	I. O. Zhaleiko, T. P. Perekhrestenko, D. I. Bilko, I. S. Dyagil, N. M. Bilko
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	2014
Schriftenreihe:	Experimental Oncology
Online Zugang:	http://jnas.nbuv.gov.ua/article/UJRN-0000294102
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Ähnliche Einträge

Tyrosine kinase inhibitors in treatment of fibrous histiocytoma
von: Maur, D., et al.
Veröffentlicht: (2009)

Influence of tyrosine proteine kinases inhibitor, genestein, on Agrobacterium – mediated plant transformation
von: V. Fedorchuk, et al.
Veröffentlicht: (2015)

Effects of tyrosine kinase and phosphatase inhibitors on mitosis progression in synchronized tobacco BY-2 cells
von: Ya. A. Sheremet, et al.
Veröffentlicht: (2012)

Inhibitors of tyrosine kinases and phosphatases as a tool for the investigation of microtubule role in plant cold response
von: Ya. A. Sheremet, et al.
Veröffentlicht: (2012)

Rational design of protein kinase inhibitors
von: S. M. Yarmoluk, et al.
Veröffentlicht: (2013)

Rational design of protein kinase inhibitors
von: Yarmoluk, S.M., et al.
Veröffentlicht: (2013)

Janus kinase inhibitors in dermatology: present and future
von: I. M. Serbina, et al.
Veröffentlicht: (2021)

Quinazoline inhibitors of protein kinase FGFR1
von: A. A. Hryshchenko, et al.
Veröffentlicht: (2010)

Assessment of high-dosed chemotherapy efficiency with following transplantation of autologous hemopoietic cells in patients with multiple myeloma
von: T. P. Zagoskina, et al.
Veröffentlicht: (2008)

Pathophysiological mechanisms of epileptic syndrome development under conditions of tyrosine-kinase activity modulation
von: M. P. Pervak
Veröffentlicht: (2017)

Accompanying immunotherapy using cord blood cryopreserved hemopoietic cells to treat patients with subacute salpingo-oophoritis
von: V. I. Grishchenko, et al.
Veröffentlicht: (2004)

Using of C60 fullerene complexes with antitumor drugs in chemotherapy
von: S. V. Prylutska
Veröffentlicht: (2014)

Calix[4]arene a-hydroxymethylphosphonic acids as potential inhibitors of protein tyrosine phosphatases
von: V. V. Trush, et al.
Veröffentlicht: (2014)

The influence of protein tyrosine phosphatase inhibitor, sodium ortovanadate, on Agrobacterium-mediated transformation of plants
von: V. V. Fedorchuk, et al.
Veröffentlicht: (2015)

The assessment of sulfonylcalix I4I arene derivatives as inhibitors of protein tyrosine phosphatases
von: V. M. Buldenko, et al.
Veröffentlicht: (2018)

Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy
von: Perekhrestenko, T., et al.
Veröffentlicht: (2023)

The determination of the relapse risk of chronic myeloid leukemia using the indicators of the functional activity of bone marrow and sokal index
von: D. I. Bilko, et al.
Veröffentlicht: (2014)

Electrical stimulations of cerebellar cortex induce more pronounced antiseizure effects after tyrosin-kinase activity inhibition
von: M. P. Pervak
Veröffentlicht: (2018)

Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia
von: Langabeer, S.E., et al.
Veröffentlicht: (2023)

Testing of a new docking scoring function on the example of inhibitors of protein tyrosine phosphatase 1B
von: Yu. Tanchuk, et al.
Veröffentlicht: (2015)

Cyclin-dependent kinases 4/6 inhibitors in combination with aromatase inhibitors in treatment of metastatic breast cancer (clinical observation)
von: M. V. Sadchykova, et al.
Veröffentlicht: (2020)

Hematological effects of the protein kinases inhibitor maleimide derivative of dimethylhydrazineinduced colorectal carcinogenesis of rats
von: I. V. Bielinska, et al.
Veröffentlicht: (2014)

Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs
von: Yurchenko, O.V., et al.
Veröffentlicht: (2010)

How to improve quality of life in patients with acute leukemia and comorbid ischemic heart disease treated with anthracycline-based induction chemotherapy
von: Skrypnyk, I., et al.
Veröffentlicht: (2023)

Synthesis and evaluation of new thiazole-containing rhodanine-3-alkanoic acids as inhibitors of protein tyrosine phosphatases and glutathione S-transferases
von: O. L. Kobzar, et al.
Veröffentlicht: (2020)

Search of protein kinase CK2 inhibitors based on purine-2,6-diones derivatives
von: M. V. Protopopov, et al.
Veröffentlicht: (2017)

The activity of adenosine monophosphate-activated protein kinase in lymphocytes under the action of hypoglycemic drugs
von: L. K. Sokolova, et al.
Veröffentlicht: (2017)

An inhibitor of Ca2+-dependent protein kinases, trifluoperazine, increases the efficiency of agrobacterium-mediated transformation of tobacco
von: V. V. Fedorchuk, et al.
Veröffentlicht: (2014)

Effect of a Rho Kinase Inhibitor on Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats
von: Q. Zhang, et al.
Veröffentlicht: (2015)

Effect of inhibitors serine/threonine protein kinases and protein phosphatases on mitosis progression of synchronized tobacco BY-2 cells
von: Ja. A. Sheremet, et al.
Veröffentlicht: (2012)

Inducible dominant negative ErbB2 rat spermatogonial line for generation of transgenic rat model and dissecting ERBB2 tyrosine kinase mediated pathways
von: Syvyk, A.E., et al.
Veröffentlicht: (2023)

Assessment of hemopoietic potential of bone marrow hemopoietic stem cells with changed initial status under effect of cryopreservation factors
von: A. N. Goltsev, et al.
Veröffentlicht: (2005)

Hemopoietic stem cells for transplantation in patients with oncohematological pathology
von: Zh. A. Misharina, et al.
Veröffentlicht: (2008)

Effect of protein kinase CK2 inhibitors on its catalytic subunits SK2α and SK2α´
von: O. V. Ostrynska, et al.
Veröffentlicht: (2014)

Proteins-partners of PH domain of BCR-ABL protein: creation of DNA constructs to uncover molecular characteristics of CML development
von: S. V. Antonenko, et al.
Veröffentlicht: (2017)

Seed pretreatment improve resistance to allelopathic stress
von: N. P. Didyk
Veröffentlicht: (2017)

Application of surface plasmon resonance phenomenon for early detection and determination of the drug concentration for treating the relapses of malignant tumors
von: Ya. Gridina, et al.
Veröffentlicht: (2020)

Optimization of cultivation technology of the genus Rhododendron L. species by through the use of drugs of biological origin
von: M. I. Shumyk, et al.
Veröffentlicht: (2011)

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy
von: I. O. Sviezhentseva, et al.
Veröffentlicht: (2015)

Synthesis and biological evaluation of novel amino-substituted derivatives of pyrido[2,3-d]pyrimidine as inhibitors of protein kinase CK2
von: Zinchenko, A.N., et al.
Veröffentlicht: (2017)